[1]
A. Finckh, D. Kyburz, B. Möller, U. Schmiedel, P. Villiger, and U. Walker, “Swiss Consensus Statement: Recommendations for optimising re-treatment with MabThera® (rituximab) in rheumatoid arthritis”, Swiss Med Wkly, vol. 140, no. 2728, p. w13073, Jul. 2010.